Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Belgium Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20051
20062
20072
20085
20097
20105
20113
20142
20153
20164
20172
20182
20192
20201
20218
20224
20233
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated15
Recruiting7
Active, not recruiting4
Unknown status3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion13
United Therapeutics7
Novartis Pharmaceuticals5
Bayer4
Lung Biotechnology PBC4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Pfizer3
Universitaire Ziekenhuizen KU Leuven3
Aerovate Therapeutics2
Biogen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension65
Hypertension, Pulmonary24
Familial Primary Pulmonary Hypertension4
Hypertension4
Cardiovascular Diseases2
Connective Tissue Diseases2
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2
Cystic Fibrosis1

Trials

Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.